GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Renalytix PLC (OTCPK:RTNXF) » Definitions » Common Stock

Renalytix (Renalytix) Common Stock : $0.37 Mil (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Renalytix Common Stock?

Renalytix's quarterly common stock increased from Sep. 2023 ($0.29 Mil) to Dec. 2023 ($0.32 Mil) and increased from Dec. 2023 ($0.32 Mil) to Mar. 2024 ($0.37 Mil).

Renalytix's annual common stock declined from Jun. 2021 ($0.23 Mil) to Jun. 2022 ($0.23 Mil) but then increased from Jun. 2022 ($0.23 Mil) to Jun. 2023 ($0.29 Mil).

Renalytix Common Stock Historical Data

The historical data trend for Renalytix's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renalytix Common Stock Chart

Renalytix Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Common Stock
Get a 7-Day Free Trial 0.16 0.19 0.23 0.23 0.29

Renalytix Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.29 0.29 0.29 0.32 0.37

Renalytix Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Renalytix (Renalytix) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Renalytix PLC (OTCPK:RTNXF) » Definitions » Common Stock
Comparable Companies
LSE:COG LSE:INHC LSE:FDBK LSE:TRLS LSE:IQAI AQSE:DXSP LSE:KOO LSE:INS VEEV GEHC TSE:2413 HQY ASX:PME RCM TXG DOCS PGNY EVH TDOC HKSE:01833
Traded in Other Exchanges
RNLX:USA RENX:UK 2O9:Germany
Address
5-7 Cranwood Street, Finsgate, London, GBR, EC1V 9EE
Website
https://www.renalytix.com
Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the common and costly chronic medical conditions globally. The company's product is KidneyIntelX which is being designed to make improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.